1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Anti-allergy 1.2.3 Anti-VEGF Agents 1.2.4 Anti-inflammatory 1.2.5 Anti-glaucoma 1.2.6 Others 1.3 Market by Application 1.3.1 Global Ophthalmic Therapeutics/Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Dry Eye 1.3.3 Allergies 1.3.4 Glaucoma 1.3.5 Infection 1.3.6 Retinal Disorders 1.3.7 Uveitis 1.3.8 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ophthalmic Therapeutics/Drug Market Perspective (2016-2027) 2.2 Ophthalmic Therapeutics/Drug Growth Trends by Regions 2.2.1 Ophthalmic Therapeutics/Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Ophthalmic Therapeutics/Drug Historic Market Share by Regions (2016-2021) 2.2.3 Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2022-2027) 2.3 Ophthalmic Therapeutics/Drug Industry Dynamic 2.3.1 Ophthalmic Therapeutics/Drug Market Trends 2.3.2 Ophthalmic Therapeutics/Drug Market Drivers 2.3.3 Ophthalmic Therapeutics/Drug Market Challenges 2.3.4 Ophthalmic Therapeutics/Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue 3.1.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue (2016-2021) 3.1.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Players (2016-2021) 3.2 Global Ophthalmic Therapeutics/Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Ophthalmic Therapeutics/Drug Revenue 3.4 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio 3.4.1 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutics/Drug Revenue in 2020 3.5 Ophthalmic Therapeutics/Drug Key Players Head office and Area Served 3.6 Key Players Ophthalmic Therapeutics/Drug Product Solution and Service 3.7 Date of Enter into Ophthalmic Therapeutics/Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ophthalmic Therapeutics/Drug Breakdown Data by Type 4.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Type (2016-2021) 4.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2022-2027) 5 Ophthalmic Therapeutics/Drug Breakdown Data by Application 5.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Application (2016-2021) 5.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Ophthalmic Therapeutics/Drug Market Size (2016-2027) 6.2 North America Ophthalmic Therapeutics/Drug Market Size by Type 6.2.1 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 6.2.2 North America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 6.2.3 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 6.3 North America Ophthalmic Therapeutics/Drug Market Size by Application 6.3.1 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 6.3.2 North America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 6.3.3 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 6.4 North America Ophthalmic Therapeutics/Drug Market Size by Country 6.4.1 North America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 6.4.2 North America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Ophthalmic Therapeutics/Drug Market Size (2016-2027) 7.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type 7.2.1 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 7.2.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 7.2.3 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application 7.3.1 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 7.3.2 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 7.3.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 7.4 Europe Ophthalmic Therapeutics/Drug Market Size by Country 7.4.1 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 7.4.2 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size (2016-2027) 8.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type 8.2.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application 8.3.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region 8.4.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Ophthalmic Therapeutics/Drug Market Size (2016-2027) 9.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type 9.2.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 9.2.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 9.2.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 9.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application 9.3.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 9.3.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 9.3.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 9.4 Latin America Ophthalmic Therapeutics/Drug Market Size by Country 9.4.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 9.4.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size (2016-2027) 10.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type 10.2.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application 10.3.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country 10.4.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Alcon 11.1.1 Alcon Company Details 11.1.2 Alcon Business Overview 11.1.3 Alcon Ophthalmic Therapeutics/Drug Introduction 11.1.4 Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.1.5 Alcon Recent Development 11.2 Johnson and Johnson Vision Care, Inc. 11.2.1 Johnson and Johnson Vision Care, Inc. Company Details 11.2.2 Johnson and Johnson Vision Care, Inc. Business Overview 11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Introduction 11.2.4 Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development 11.3 Bausch & Lomb Incorporated 11.3.1 Bausch & Lomb Incorporated Company Details 11.3.2 Bausch & Lomb Incorporated Business Overview 11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Introduction 11.3.4 Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.3.5 Bausch & Lomb Incorporated Recent Development 11.4 Novartis AG 11.4.1 Novartis AG Company Details 11.4.2 Novartis AG Business Overview 11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Introduction 11.4.4 Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.4.5 Novartis AG Recent Development 11.5 Merck Sharp & Dohme Corp. 11.5.1 Merck Sharp & Dohme Corp. Company Details 11.5.2 Merck Sharp & Dohme Corp. Business Overview 11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Introduction 11.5.4 Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.5.5 Merck Sharp & Dohme Corp. Recent Development 11.6 Regeneron Pharmaceuticals Inc. 11.6.1 Regeneron Pharmaceuticals Inc. Company Details 11.6.2 Regeneron Pharmaceuticals Inc. Business Overview 11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Introduction 11.6.4 Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.6.5 Regeneron Pharmaceuticals Inc. Recent Development 11.7 Allergan 11.7.1 Allergan Company Details 11.7.2 Allergan Business Overview 11.7.3 Allergan Ophthalmic Therapeutics/Drug Introduction 11.7.4 Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.7.5 Allergan Recent Development 11.8 Pfizer Inc. 11.8.1 Pfizer Inc. Company Details 11.8.2 Pfizer Inc. Business Overview 11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Introduction 11.8.4 Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.8.5 Pfizer Inc. Recent Development 11.9 Valeant 11.9.1 Valeant Company Details 11.9.2 Valeant Business Overview 11.9.3 Valeant Ophthalmic Therapeutics/Drug Introduction 11.9.4 Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.9.5 Valeant Recent Development 11.10 Bayer AG 11.10.1 Bayer AG Company Details 11.10.2 Bayer AG Business Overview 11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Introduction 11.10.4 Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.10.5 Bayer AG Recent Development 11.11 Santen Pharmaceuticals Co. Ltd 11.11.1 Santen Pharmaceuticals Co. Ltd Company Details 11.11.2 Santen Pharmaceuticals Co. Ltd Business Overview 11.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Introduction 11.11.4 Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.11.5 Santen Pharmaceuticals Co. Ltd Recent Development 11.12 Genentech, Inc. 11.12.1 Genentech, Inc. Company Details 11.12.2 Genentech, Inc. Business Overview 11.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Introduction 11.12.4 Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.12.5 Genentech, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Anti-allergy Table 3. Key Players of Anti-VEGF Agents Table 4. Key Players of Anti-inflammatory Table 5. Key Players of Anti-glaucoma Table 6. Key Players of Others Table 7. Global Ophthalmic Therapeutics/Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Ophthalmic Therapeutics/Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Ophthalmic Therapeutics/Drug Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Ophthalmic Therapeutics/Drug Market Share by Regions (2016-2021) Table 11. Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Ophthalmic Therapeutics/Drug Market Share by Regions (2022-2027) Table 13. Ophthalmic Therapeutics/Drug Market Trends Table 14. Ophthalmic Therapeutics/Drug Market Drivers Table 15. Ophthalmic Therapeutics/Drug Market Challenges Table 16. Ophthalmic Therapeutics/Drug Market Restraints Table 17. Global Ophthalmic Therapeutics/Drug Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Ophthalmic Therapeutics/Drug Market Share by Players (2016-2021) Table 19. Global Top Ophthalmic Therapeutics/Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutics/Drug as of 2020) Table 20. Ranking of Global Top Ophthalmic Therapeutics/Drug Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Ophthalmic Therapeutics/Drug Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Ophthalmic Therapeutics/Drug Product Solution and Service Table 24. Date of Enter into Ophthalmic Therapeutics/Drug Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million) Table 27. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2016-2021) Table 28. Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Ophthalmic Therapeutics/Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Application (2016-2021) Table 32. Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million) Table 35. North America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million) Table 37. North America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million) Table 64. Alcon Company Details Table 65. Alcon Business Overview Table 66. Alcon Ophthalmic Therapeutics/Drug Product Table 67. Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 68. Alcon Recent Development Table 69. Johnson and Johnson Vision Care, Inc. Company Details Table 70. Johnson and Johnson Vision Care, Inc. Business Overview Table 71. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Table 72. Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 73. Johnson and Johnson Vision Care, Inc. Recent Development Table 74. Bausch & Lomb Incorporated Company Details Table 75. Bausch & Lomb Incorporated Business Overview Table 76. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Table 77. Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 78. Bausch & Lomb Incorporated Recent Development Table 79. Novartis AG Company Details Table 80. Novartis AG Business Overview Table 81. Novartis AG Ophthalmic Therapeutics/Drug Product Table 82. Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 83. Novartis AG Recent Development Table 84. Merck Sharp & Dohme Corp. Company Details Table 85. Merck Sharp & Dohme Corp. Business Overview Table 86. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Table 87. Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 88. Merck Sharp & Dohme Corp. Recent Development Table 89. Regeneron Pharmaceuticals Inc. Company Details Table 90. Regeneron Pharmaceuticals Inc. Business Overview Table 91. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Table 92. Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 93. Regeneron Pharmaceuticals Inc. Recent Development Table 94. Allergan Company Details Table 95. Allergan Business Overview Table 96. Allergan Ophthalmic Therapeutics/Drug Product Table 97. Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 98. Allergan Recent Development Table 99. Pfizer Inc. Company Details Table 100. Pfizer Inc. Business Overview Table 101. Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 102. Pfizer Inc. Recent Development Table 103. Valeant Company Details Table 104. Valeant Business Overview Table 105. Valeant Ophthalmic Therapeutics/Drug Product Table 106. Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 107. Valeant Recent Development Table 108. Bayer AG Company Details Table 109. Bayer AG Business Overview Table 110. Bayer AG Ophthalmic Therapeutics/Drug Product Table 111. Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 112. Bayer AG Recent Development Table 113. Santen Pharmaceuticals Co. Ltd Company Details Table 114. Santen Pharmaceuticals Co. Ltd Business Overview Table 115. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Table 116. Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 117. Santen Pharmaceuticals Co. Ltd Recent Development Table 118. Genentech, Inc. Company Details Table 119. Genentech, Inc. Business Overview Table 120. Genentech, Inc. Ophthalmic Therapeutics/Drug Product Table 121. Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million) Table 122. Genentech, Inc. Recent Development Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Ophthalmic Therapeutics/Drug Market Share by Type: 2020 VS 2027 Figure 2. Anti-allergy Features Figure 3. Anti-VEGF Agents Features Figure 4. Anti-inflammatory Features Figure 5. Anti-glaucoma Features Figure 6. Others Features Figure 7. Global Ophthalmic Therapeutics/Drug Market Share by Application: 2020 VS 2027 Figure 8. Dry Eye Case Studies Figure 9. Allergies Case Studies Figure 10. Glaucoma Case Studies Figure 11. Infection Case Studies Figure 12. Retinal Disorders Case Studies Figure 13. Uveitis Case Studies Figure 14. Others Case Studies Figure 15. Ophthalmic Therapeutics/Drug Report Years Considered Figure 16. Global Ophthalmic Therapeutics/Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Ophthalmic Therapeutics/Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Ophthalmic Therapeutics/Drug Market Share by Regions: 2020 VS 2027 Figure 19. Global Ophthalmic Therapeutics/Drug Market Share by Regions (2022-2027) Figure 20. Global Ophthalmic Therapeutics/Drug Market Share by Players in 2020 Figure 21. Global Top Ophthalmic Therapeutics/Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutics/Drug as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Ophthalmic Therapeutics/Drug Revenue in 2020 Figure 23. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2016-2021) Figure 24. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2022-2027) Figure 25. North America Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027) Figure 27. North America Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027) Figure 28. North America Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027) Figure 29. United States Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027) Figure 33. Europe Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027) Figure 34. Europe Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027) Figure 35. Germany Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027) Figure 43. Asia-Pacific Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027) Figure 44. Asia-Pacific Ophthalmic Therapeutics/Drug Market Share by Region (2016-2027) Figure 45. China Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027) Figure 53. Latin America Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027) Figure 54. Latin America Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027) Figure 55. Mexico Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027) Figure 59. Middle East & Africa Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027) Figure 60. Middle East & Africa Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027) Figure 61. Turkey Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Alcon Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 65. Johnson and Johnson Vision Care, Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 66. Bausch & Lomb Incorporated Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 67. Novartis AG Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 68. Merck Sharp & Dohme Corp. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 69. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 70. Allergan Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 71. Pfizer Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 72. Valeant Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 73. Bayer AG Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 74. Santen Pharmaceuticals Co. Ltd Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 75. Genentech, Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Alcon Johnson and Johnson Vision Care, Inc. Bausch & Lomb Incorporated Novartis AG Merck Sharp & Dohme Corp. Regeneron Pharmaceuticals Inc. Allergan Pfizer Inc. Valeant Bayer AG Santen Pharmaceuticals Co. Ltd Genentech, Inc.